SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN)
BTRN 35.92-0.7%Oct 29 4:00 PM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: finbar who wrote (1470)2/25/2007 8:25:32 PM
From: finbar  Read Replies (1) of 1475
 
not very scientific, but on the MEDI website they have within the last 2 weeks advanced the little bar that represents the progress of Medi-507 - which they call sipluzamab to the phase II crosshair. BTRN gets a 1 or 2 mm milestone if and when this happens - never been able to tell if the compound is 1st or 2nd generation which accounts for the difference in milestone payable.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News